Home › Funds › Patient Capital Management, LLC › META

Patient Capital Management, LLC position in META

META PLATFORMS INC · Technology

Patient Capital Management, LLC reported holding 171,500 shares of META (META PLATFORMS INC) in its Q3 2026 13F filing — a position valued at US$124.4M, representing 4.20% of its reported portfolio and ranking #10 among its reported holdings. Patient Capital Management, LLC has disclosed META holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)171.50K sh
Reported value held$124.37M
Portfolio Weight4.20%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Capital Management, LLC's META position evolved

Patient Capital Management, LLC first disclosed a stake in META in Q3 2023 at 189,352 shares (US$56.8M). The position peaked in Q3 2026 at 171,500 shares, worth US$124.4M. Across 13 filings, Patient Capital Management, LLC increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 171,500 shares valued at US$124.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 189.35K $56.85M New
Q4 2023 188.42K $66.69M Hold
Q1 2024 165.00K $80.12M Reduce
Q2 2024 159.93K $80.64M Reduce
Q3 2024 147.82K $84.62M Reduce
Q4 2024 147.63K $86.44M Hold
Q1 2025 145.67K $83.96M Reduce
Q2 2025 144.29K $106.50M Reduce
Q3 2025 144.00K $105.75M Hold
Q4 2025 143.09K $94.45M Reduce
Q1 2026 171.09K $97.88M Add
Q2 2026 170.79K $96.20M Hold
Q3 2026 171.50K $124.37M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About META and 13F data

META (META PLATFORMS INC) is a Technology company. 30 other funds we track also report a position in META — the largest reported positions include Vanguard Group (US$132.02B), VANGUARD CAPITAL MANAGEMENT LLC (US$104.68B), Fidelity Management & Research (FMR) (US$73.55B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding META

All META fund holders →

FAQ

How long has Patient Capital Management, LLC held META?

Patient Capital Management, LLC has disclosed META holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Patient Capital Management, LLC's current position in META?

As of Q3 2026, Patient Capital Management, LLC holds 171.50K shares of META (META PLATFORMS INC), valued at $124.37M, representing 4.20% of its reported portfolio and ranking #10.

Has Patient Capital Management, LLC been buying or selling META?

In the latest 13F filing (Q3 2026), Patient Capital Management, LLC held unchanged its position in META. The position peaked in Q3 2026 at 171.50K shares.

Which other funds hold META?

Other major institutional holders of META include Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Fidelity Management & Research (FMR), among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.